289 related articles for article (PubMed ID: 17577823)
1. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
Overgaard UM; Helweg-Larsen J
Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
[TBL] [Abstract][Full Text] [Related]
2. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden.
Mikaelsson L; Jacobsson G; Andersson R
J Infect; 2006 Oct; 53(4):260-5. PubMed ID: 16403575
[TBL] [Abstract][Full Text] [Related]
4. [Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].
Blum T; Roth A; Mauch H; Erbes R; Lode H
Dtsch Med Wochenschr; 2006 Jul; 131(27):1515-20. PubMed ID: 16817100
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
[TBL] [Abstract][Full Text] [Related]
7. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.
Enomoto T; Azuma A; Kohno A; Kaneko K; Saito H; Kametaka M; Usuki J; Gemma A; Kudoh S; Nakamura S
Respirology; 2010 Jan; 15(1):126-31. PubMed ID: 19947989
[TBL] [Abstract][Full Text] [Related]
8. The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.
Wu AK; Cheng VC; Tang BS; Hung IF; Lee RA; Hui DS; Yuen KY
BMC Infect Dis; 2004 Dec; 4(1):57. PubMed ID: 15588295
[TBL] [Abstract][Full Text] [Related]
9. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
Schürmann M; Schürmann D; Schindler R; Meisel C; Liman P; Kruse J; Enghard P; König J; Schmidt D; Reinke P; Nickel P
Transpl Immunol; 2013 Jun; 28(4):159-63. PubMed ID: 23684946
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.
Mansharamani NG; Balachandran D; Vernovsky I; Garland R; Koziel H
Chest; 2000 Sep; 118(3):712-20. PubMed ID: 10988193
[TBL] [Abstract][Full Text] [Related]
11. Use of the relationship between absolute lymphocyte count and CD4 count to improve earlier consideration of pneumocystis pneumonia in HIV-positive emergency department patients with pneumonia.
Napoli AM; Maughan B; Murray R; Maloy K; Milzman D
J Emerg Med; 2013 Jan; 44(1):28-35. PubMed ID: 22819682
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.
Costiniuk CT; Fergusson DA; Doucette S; Angel JB
PLoS One; 2011; 6(12):e28570. PubMed ID: 22194853
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS; Lu JJ; Perng CL; Chang FY
J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment.
Roblot F; Le Moal G; Kauffmann-Lacroix C; Bastides F; Boutoille D; Verdon R; Godet C; Tattevin P;
Scand J Infect Dis; 2014 Mar; 46(3):210-4. PubMed ID: 24450839
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.
Babic-Erceg A; Vilibic-Cavlek T; Erceg M; Mlinaric-Missoni E; Begovac J
Acta Microbiol Immunol Hung; 2014 Jun; 61(2):181-8. PubMed ID: 24939686
[TBL] [Abstract][Full Text] [Related]
16. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
[TBL] [Abstract][Full Text] [Related]
17. Detection of Pneumocystis jirovecii by quantitative real-time PCR in oral rinses from Pneumocystis pneumonia asymptomatic human immunodeficiency virus patients.
Fraczek MG; Ahmad S; Richardson M; Kirwan M; Bowyer P; Denning DW; Rautemaa R
J Mycol Med; 2019 Jun; 29(2):107-111. PubMed ID: 31047784
[TBL] [Abstract][Full Text] [Related]
18. An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia.
Brunot V; Pernin V; Chartier C; Garrigue V; Vetromile F; Szwarc I; Delmas S; Portalès P; Basset D; Mourad G
Transplant Proc; 2012 Nov; 44(9):2818-20. PubMed ID: 23146531
[TBL] [Abstract][Full Text] [Related]
19. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.
Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J
J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia.
Aderaye G; Bruchfeld J; Aseffa G; Nigussie Y; Melaku K; Woldeamanuel Y; Asrat D; Worku A; Gaegziabher H; Lebaad M; Lindquist L
Scand J Infect Dis; 2007; 39(11-12):1045-53. PubMed ID: 17852928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
